Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2023-11, Vol.35 (11), p.22
Main Author: Mirasol, Feliza
Format: Article
Language:English
Subjects:
Monoclonal antibodies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 11
container_start_page 22
container_title Pharmaceutical technology Europe
container_volume 35
creator Mirasol, Feliza
description
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A774988651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A774988651</galeid><sourcerecordid>A774988651</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1421-f3e642e5dfc0f90bf5ce0becb909c06fd18f65a34f509c0bd1d80d2fb2c059b63</originalsourceid><addsrcrecordid>eNpt0ctKAzEUBuBZKFir7xBw25HMJXNxV4pWoeJC221JMifTSCapcyYFn8cXNa0KFUogCT_fOUnIWTRKSpbFZV2UF9El4julIWDZKPqaG-BW25a8Sm4gXm7JAhCdRaJ615FuKsLO9WSle27ICuTgerwjz846aZwNGbeDFq75JLsD2R0I6bj1isvB90Bww_ez7rThvR404IQIP_xR3J9M_JYED0i81R8eiNxwY8C2gFfRueIG4fp3HUfLh_u32WO8eJk_zaaLuE3yNIlVBkWeAmuUpKqmQjEJVIAUNa0lLVSTVKpgPMsV2weiSZqKNqkSqaSsFkU2jm5--rbhPmttlRt6LjuNcj0ty7yuqoIlQcUnVAsWwuudBaVD_M_fnvBhNNBpebJgclQgPGobfkRb1O1mwJZ7xGP-DS4QmOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges</title><source>EBSCOhost Business Source Ultimate</source><source>EZB Electronic Journals Library</source><creator>Mirasol, Feliza</creator><creatorcontrib>Mirasol, Feliza</creatorcontrib><identifier>ISSN: 1753-7967</identifier><language>eng</language><publisher>Intellisphere, LLC</publisher><subject>Monoclonal antibodies</subject><ispartof>Pharmaceutical technology Europe, 2023-11, Vol.35 (11), p.22</ispartof><rights>COPYRIGHT 2023 Intellisphere, LLC</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Mirasol, Feliza</creatorcontrib><title>Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges</title><title>Pharmaceutical technology Europe</title><subject>Monoclonal antibodies</subject><issn>1753-7967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpt0ctKAzEUBuBZKFir7xBw25HMJXNxV4pWoeJC221JMifTSCapcyYFn8cXNa0KFUogCT_fOUnIWTRKSpbFZV2UF9El4julIWDZKPqaG-BW25a8Sm4gXm7JAhCdRaJ615FuKsLO9WSle27ICuTgerwjz846aZwNGbeDFq75JLsD2R0I6bj1isvB90Bww_ez7rThvR404IQIP_xR3J9M_JYED0i81R8eiNxwY8C2gFfRueIG4fp3HUfLh_u32WO8eJk_zaaLuE3yNIlVBkWeAmuUpKqmQjEJVIAUNa0lLVSTVKpgPMsV2weiSZqKNqkSqaSsFkU2jm5--rbhPmttlRt6LjuNcj0ty7yuqoIlQcUnVAsWwuudBaVD_M_fnvBhNNBpebJgclQgPGobfkRb1O1mwJZ7xGP-DS4QmOg</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Mirasol, Feliza</creator><general>Intellisphere, LLC</general><scope>N95</scope><scope>XI7</scope></search><sort><creationdate>20231101</creationdate><title>Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges</title><author>Mirasol, Feliza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1421-f3e642e5dfc0f90bf5ce0becb909c06fd18f65a34f509c0bd1d80d2fb2c059b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Monoclonal antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirasol, Feliza</creatorcontrib><collection>Gale Business: Insights</collection><collection>Business Insights: Essentials</collection><jtitle>Pharmaceutical technology Europe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirasol, Feliza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges</atitle><jtitle>Pharmaceutical technology Europe</jtitle><date>2023-11-01</date><risdate>2023</risdate><volume>35</volume><issue>11</issue><spage>22</spage><pages>22-</pages><issn>1753-7967</issn><pub>Intellisphere, LLC</pub></addata></record>
fulltext fulltext
identifier ISSN: 1753-7967
ispartof Pharmaceutical technology Europe, 2023-11, Vol.35 (11), p.22
issn 1753-7967
language eng
recordid cdi_gale_infotracmisc_A774988651
source EBSCOhost Business Source Ultimate; EZB Electronic Journals Library
subjects Monoclonal antibodies
title Gleaning Scale-Up Lessons from mAbs for Viral Vectors: Monoclonal antibody viral vector manufacture share similarities, but vector scale up faces unique challenges
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T22%3A56%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gleaning%20Scale-Up%20Lessons%20from%20mAbs%20for%20Viral%20Vectors:%20Monoclonal%20antibody%20viral%20vector%20manufacture%20share%20similarities,%20but%20vector%20scale%20up%20faces%20unique%20challenges&rft.jtitle=Pharmaceutical%20technology%20Europe&rft.au=Mirasol,%20Feliza&rft.date=2023-11-01&rft.volume=35&rft.issue=11&rft.spage=22&rft.pages=22-&rft.issn=1753-7967&rft_id=info:doi/&rft_dat=%3Cgale%3EA774988651%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g1421-f3e642e5dfc0f90bf5ce0becb909c06fd18f65a34f509c0bd1d80d2fb2c059b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A774988651&rfr_iscdi=true